coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    The Wbc (hereford City) PCN, Herefordshire, County of (LAD) · Health Inequalities Profile

    PCN U50083 · NHS Herefordshire and Worcestershire Integrated Care Board · 3 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    31,511

    Registered population

    57.5% aged 18–64

    23.6%

    Aged 65+

    ICB 24.3% · England 17.9%

    4.3%

    Ethnic minority (non-White)

    1.8% Asian · England 9.6%

    10.8%

    In IMD quintile 1

    ICB 10.9% · England 21.0%

    ~3,020

    Core20 residents (est.)

    Resident basis; registered basis ~3,637 · see page 3

    5,747

    Hypertension register

    +7.12% in 3 yrs · England +5.60%

    346

    SMI register

    20.1% of Herefordshire, County of (LAD)'s

    829

    COPD register

    Reviews -13.08% in 3 yrs

    Forecast to 2030

    6,839

    Hypertension patients, 2030

    +1,092 on today

    100.0%

    QRISK ≥20% on statins, 2030

    +13.37pp over 3 yrs

    6.0%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    -13.1%
    Respiratory annual reviews fell against rising benchmarks.

    COPD reviews fell 13.1% over 2023 to 2025 to 70.1% (England +2.8% to 76.4%); asthma reviews are 62.0% (757 unreviewed), which may reflect recall.

    87.1%
    Pre-school MMR2 coverage lags 24-month uptake.

    In Q1 2025/26, 24-month MMR1 reached 95.8% (target 95.0%), but age-five MMR2 is 87.1%, 6.4 pp below age-five MMR1 at 93.5%.

    +27.3%
    High-risk lipid therapy rose faster than England.

    QRISK ≥ 20% lipid therapy rose 27.3% over 2023 to 2025 to 62.3% (England +6.2% to 63.6%), though 2026 items cost £2.70 (England £1.86).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Older patients exceed England levels while Belmont Medical Centre concentrates child cohorts

    Across 31,511 registered patients, 23.6% (7,431) are aged 65+, below Herefordshire's 28.3% and the ICB's 24.3%, but above England's 17.9%. Children aged 0–17 comprise 18.9% (5,952), exceeding Herefordshire (16.5%) and the ICB (17.8%) while below England (19.6%), with 22.2% at Belmont Medical Centre, 17.4% at Cantilupe Surgery, and 16.7% at Wargrave House Surgery. Census usual residents in associated areas are 95.7% White (England 81.1%) and 1.8% Asian or Asian British (England 9.6%).

    Age profile

    0–1718.9%
    18–6457.5%
    65+23.6%

    65+: ICB 24.3%, England 17.9%

    Ethnicity

    White95.7%
    Asian1.8%
    Mixed1.2%
    Other0.7%
    Black0.5%

    Older people · falls rows are Herefordshire, County of (LAD) local-authority (LA) data, not PCN

    MeasureLocalWest MidlandsEnglandPeriod
    Falls admissions, 65+, per 100,000 (Herefordshire LA)1,4721,8471,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)77.7%—81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)58.0%—57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Herefordshire LA)7729229552024/25
    Falls deaths, all ages, per 100,000 (Herefordshire LA)10.417.514.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation averages 10.8% across the PCN but reaches 24.9% at Belmont Medical Centre

    The PCN Core20 cohort is 10.8%, above Herefordshire (7.8%), in line with the ICB (10.9%), and below England (21.0%). Registered Core20 share is concentrated: Belmont Medical Centre holds 24.9% (2,736 estimated patients), Wargrave House Surgery holds 7.9% (644), and Cantilupe Surgery holds 2.1% (257). Practice-level estimates sum to 3,637 patients, compared with an estimated resident population of 3,020 (about 3,000) across national deciles 1 and 2. Reconciling resident and registered lists is necessary before deploying targeted Core20 outreach.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Belmont24.9% · 2,736 patients
    Wargrave House7.9% · 644 patients
    Cantilupe2.1% · 257 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    346

    SMI register

    1.10% recorded prevalence

    265

    Learning disability register

    0.84% recorded prevalence

    31

    Care homes, 879 beds

    In the PCN catchment

    8.7%

    Provide unpaid care

    Herefordshire, County of (LAD), Census 2021

    Recorded severe mental illness prevalence is 1.1% (346 patients), above Herefordshire (0.9%), the ICB (0.8%) and England (1.0%). Recorded learning disability prevalence is 0.8% (265 patients; Herefordshire 0.6%, ICB 0.6%, England 0.6%). Active care homes in the PCN catchment total 31 with 879 beds, though bed capacity does not establish resident registrations.

    Severe mental illness: physical health checks

    Severe mental illness prevalence is 1.1% (England 1.0%). Recorded blood pressure checks are 76.4% (England 83.4%) and BMI checks are 75.5% (England 82.1%), both trailing national benchmarks.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    5,747

    Hypertension register

    +7.12%

    Register growth, 3 yrs

    Herefordshire, County of (LAD) +10.36% · England +5.60%

    +1.67pp

    BP control, under 80

    ≤140/90 · +1.33pp aged 80+

    +1,092

    More patients by 2030

    Forecast 6,839 (21.01%)

    Hypertension case-finding and control

    Hypertension prevalence is 18.3% (5,747 patients), exceeding England (15.2%) but below Herefordshire (19.2%) and the ICB (18.7%). Recorded prevalence is 16.2% at Belmont Medical Centre, 18.5% at Wargrave House Surgery, and 19.9% at Cantilupe Surgery. Crude register comparisons suggest a modelled range of -948 to +296 patients. Treated to target reaches 70.7%, above England (70.3%) and the county (68.6%). Lower recorded prevalence at Belmont Medical Centre could reflect unverified case-mix or detection differences that clinical audits would test.

    Lipids and statins

    For patients with QRISK ≥ 20%, lipid-lowering therapy is 62.3%, trailing England (63.6%) despite a +27.3% change over 2023 to 2025 (England +6.2%). Statin coverage in diabetes without CVD is 74.8% (England 73.2%). Fewer at-risk patients receive lipid-lowering therapy than England's rate, making primary prevention recall a potential review area.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202651,016£2.70£2.17£1.86£137,743
    Cardiovascular (all), 202564,465£4.90£4.41£3.33£315,878

    For lipid-modifying drugs in 2026, the PCN prescribed 51,016 items at £2.70 per item, exceeding England (£1.86) and the ICB (£2.17). Across these 51,016 items, the PCN spent £42,853 more than at England's unit cost. Higher unit costs than national and system benchmarks highlight an opportunity to review prescribing choices without compromising clinical control.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −4.55%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +1.59%

    Asthma prevalence, PCN 3-yr % change

    COPD prevalence is 2.6% (829 patients; England 1.9%), but 12-month reviews reached 70.1% (England 76.4%) and fell 13.1% over 2023 to 2025 (England +2.8%). Asthma prevalence is 6.7% (1,992 patients; England 6.6%), yet 12-month reviews fell 4.5% over 2023 to 2025 (England +4.4%) to 62.0% (England 65.7%), leaving about 760 patients without a recorded review. At Wargrave House Surgery, asthma reviews were 58.5%. Falling review rates are consistent with recall or capacity gaps that workflow audits would test.

    Cancer register and children's immunisation

    Cancer prevalence is 4.8% (1,502 patients; England 3.8%). In Q1 2025/26, MMR1 coverage at 24 months was 95.8% (0.8 pp above the 95.0% target). At age five, MMR2 coverage was 87.1% (7.9 pp below the 95.0% target), showing a 6.4 pp difference from age-five MMR1 (93.5%). The 4-in-1 pre-school booster was also 87.1% (7.9 pp below target). These gaps could reflect recall timing differences that pre-school audits would test.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months97.1%

    England 91.0%

    6-in-1 complete primary course at 24 months97.2%

    England 92.2%

    MMR dose 1 at 24 months95.8%

    England 88.3%

    MMR dose 2 at age 587.1%

    England 82.8%

    4-in-1 pre-school booster at age 587.1%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    56.2%

    Herefordshire and Worcestershire ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~770

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Herefordshire and Worcestershire ICBEnglandNo usable stageStaged cancers
    Prostate52.4%53.2%23%706
    Bowel51.4%47.0%15%657
    Breast88.9%85.4%28%611
    Lung32.1%33.8%13%473
    Skin cancer86.3%87.8%13%314

    In 2022, 56.2% of cancers in NHS Herefordshire and Worcestershire ICB were diagnosed at stage 1 or 2 among cases with a known stage (2,285 of 4,068), compared to 55.3% in England, remaining 18.8 pp below the 75.0% national ambition for 2028 (a gap of 766 cases). Known-stage completeness was 68.0% (4,068 of 5,984 registered cases; England 67.0%). ICB figures describe the wider system, not PCN performance. Locally, PCN breast screening coverage is 67.5% (England 69.9%, ICB 75.0%), with lower rates at Belmont Medical Centre (63.3%) and Wargrave House Surgery (64.7%). Prioritising breast screening recall may help improve timely detection across the system.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026, Wye Valley NHS Trust achieved 85.1% on the 62-day cancer referral to treatment standard, exceeding Worcestershire Acute Hospitals NHS Trust (53.0%), Gloucestershire Hospitals NHS Foundation Trust (74.6%), NHS Herefordshire and Worcestershire Integrated Care Board (61.7%) and England (71.2%). Wye Valley also reached 86.5% on the 28-day faster diagnosis standard (ICB 83.0%, England 79.3%) and 96.2% on the 31-day standard (ICB 89.9%, England 92.5%). Diagnostic 6+ week waits at Wye Valley were 19.3% overall (Gloucestershire 18.3%, England 23.1%, Worcestershire Acute 30.6%), though colonoscopy waits reached 40.0% (England 30.8%). Provider figures describe system activity, not PCN performance.

    Pathways within standard (%)Wye ValleyGloucestershireWorcestershire AcuteHerefordshire and Worcestershire ICBEngland
    28-day faster diagnosis (75%)86.5274.4382.5083.0579.32
    31-day treatment (96%)96.2594.6686.9889.9592.50
    62-day referral to treatment (85%)85.1474.5952.9961.7171.16
    Diagnostic waits over 6 weeks (%)Wye ValleyGloucestershireWorcestershire AcuteEngland
    MRI18.2315.9622.5121.40
    CT0.167.4411.099.92
    Echocardiography30.2456.1710.2528.48
    Colonoscopy40.0040.009.9130.83
    Gastroscopy26.0931.559.5329.02
    All 15 DM01 tests19.3518.3430.6123.14
    Community services activityHerefordshire, County of residentsHerefordshire and Worcestershire ICB
    Care contacts43,135124,085
    Referrals5,97023,130
    Patients with a contact9,55030,665

    Community services (residents of Herefordshire, County of), Jun 2026 (provisional). In provisional June 2026 experimental statistics, Herefordshire, County of recorded 5,970 community referrals and 9,550 patients with a community care contact, alongside 23,130 referrals across NHS Herefordshire and Worcestershire Integrated Care Board. Adults aged 65+ represented 67.4% of resident contacts (29,080 of 43,135). These figures reflect wider-system activity across submitting providers rather than PCN-level activity.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    In 2025/26, QOF clinical-domain achievement was 100.0% at Cantilupe Surgery, 100.0% at Wargrave House Surgery, and 100.0% at Belmont Medical Centre. The England comparator was 97.1%. For overall achievement, Cantilupe Surgery achieved 99.0%, Wargrave House Surgery achieved 99.2%, and Belmont Medical Centre achieved 93.8%. The England comparator was 92.5%.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Cantilupe Surgery1162.161.2%70.8%82.1%
    Belmont8324.965.4%68.5%71.4%
    Wargrave House967.936.4%58.5%61.1%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNHerefordshire, County of (LAD)AssetPCNHerefordshire, County of (LAD)
    Care homes (catchment)31 (879 beds)n/aSchools (catchment)65n/a
    Children's centres37Places of worship69341
    Libraries39Day centres (VCS)11
    Carers support groups (VCS)11Primary schools (LA maintained)1143
    Primary academies1228Special schools14

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma and COPD review recall

    Asthma reviews are 62.0% (England 65.7%, ICB 66.4%), falling 4.5% over 2023 to 2025 (England +4.4%), a scale gap of 757 across 1,992 registered; COPD reviews are 70.1% (England 76.4%). For discussion: practices could run a single recall template for asthma and COPD reviews, trial flexible slots, and review inhalers. Moderate effort to run.

    Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.

    Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.

    Option 2

    Combined SMI physical health check outreach

    Across 346 SMI patients, BP checks are 76.4% (England 83.4%, falling 0.8 pp vs +4.4 pp) and BMI checks are 75.5% (England 82.1%, falling 2.8 pp vs +5.1 pp). For discussion: audit partial check recording, offer combined appointments or home visits, and raise shared recording with system partners. Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Option 3

    Pre-school MMR2 and booster recall

    In Q1 2025/26, age-five MMR2 and 4-in-1 booster coverage are both 87.1% (below the 95.0% target by 7.9 pp), a 6.4 pp difference from age-five MMR1 (93.5%) across 62 children. For discussion: practices could run targeted recall for children with one MMR dose, offer flexible clinics, and review call-recall interfaces. Low cost, quick to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Older adult care coordination (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Targeted Core20 list reconciliation (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical check recall audit (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Targeted blood pressure case-finding (p5)Hypertension: QOF prevalenceCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall outreach (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Breast screening uptake initiative (p7)Breast screening coverage: aged 53 to 70 years old—PCN
    Option 1 · Structured asthma and COPD review recall (p12)COPD register · COPD patients with a review in the last 12 months · Patients with COPD who had a review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · Combined SMI physical health check outreach (p12)Severe mental illness register · SMI register with a BP check in the last 12 months · Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Option 3 · Pre-school MMR2 and booster recall (p12)MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 5 · 4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15